Companies / AVH

AVITA MEDICAL INC.

ASX:AVHPharmaceuticals, Biotechnology & Life Sciences
154.8M shares on issueASX (delayed) · snapshot 28 Oct 2026186.3M fully diluted+20.3% if every option and right converts$4.51price · delayed$658.0MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 83.1% of what they think they own, once every option and right converts.

Low
Dilution risk

Options/rights overhang 20% of shares; 1 cash raise in 24 months; 1% of shares in the money

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runwayno data — no quarterly (4C/5B) or half-year/annual (4D/4E) cash report on record
Share-count growth (24m)0.0%no issuance filings since 2024; measured to the latest Appendix 2A, not to the share count above
Raise cadence (24m)1 cash raise
Options & rights overhang20.3% of shares
In-the-money supply0.6% of shares
Pending proposed issuesnone

AVITA MEDICAL INC. had 155M ordinary shares as of October 2026, its latest share-count filing; no share-count growth figure is available for the period because the ASX Appendix 2A series ended before this date and no new issuance filings have been lodged since January 2024. The company conducted one capital raising in the 24-month window, a placement in August 2025 that raised A$22.7M. Options and rights on issue could convert into 31M new shares, representing a 20.3% overhang of the current share count, with 1% of shares in the money; the nearest expiry is December 2031. AVITA does not currently have a quarterly or half-yearly cash report runway figure on record. No proposed securities issues are pending.

AI-generated summary of this page's cited filings · updated 28 Oct 2026
Quick answers · 3

When did AVH last raise capital?

The last capital raise in Avita Medical's filings is Placement of $22.7M announced 13 Aug 2025, one of 1 cash raises in 24 months.

How much placement capacity does AVH have left?

None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.

When do AVH's options expire?

Unexercised options and rights equal 20.3% of Avita Medical's shares on issue; the nearest expiry is Dec 2031.

Get told when this changes
Get AVH alerts
Free for up to 2 companies. A daily email when AVH raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
20.3%
Options & rights overhang
0.6%
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply · most strikes not on record
0
Raises · last 12 months
—
Cash cover · no cash report

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 154.8M per ASX (delayed) (snapshot 28 Oct 2026).
130M140M150MDec 24Nov 25Oct 26Cash raise · 13 Aug 2025154.8M

Cash runway

No cash report on record. No Appendix 4C / 5BQuarterly cash reports: cash in, cash out and cash on hand. Explorers lodge a 5B, other early-stage companies a 4C. quarterly cash report and no 4D/4E half-year or annual cash-flow statement is on record for this company, so cash runway cannot be computed.

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
6 Oct 20263H · cancellationAVH : CHESS DEPOSITARY INTERESTS73.3MAppendix 3H
6 Oct 20263G · unquotedCHESS DEPOSITARY INTERESTS73.3MAppendix 3G
15 Sept 20263H · cancellationAVH : CHESS DEPOSITARY INTERESTS73.3MAppendix 3H
10 Sept 20263G · unquotedCHESS DEPOSITARY INTERESTS81.3MAppendix 3G
10 Sept 20263G · unquotedAVH : CHESS DEPOSITARY INTERESTS81.3MAppendix 3G

Each filing states the count for the security it names, as at its own reference date and in the units of that filing — so the newest row (73.3M) need not equal the current count above (154.8M).

Free account
121 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock AVH freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock AVH freeSee plans

Capital raises

1 cash raise in the last 24 months · 0 in the last 12 months

$22.7M
Placement
13 Aug 2025
Free account
1 raise on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock AVH freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
38 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock AVH freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

No Appendix 3B in the last 12 months reports an issue under the 15% placement capacity (as at 2026-10-28).
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock AVH freeSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

20.3%
Options & rights overhang · of current shares
0.6%
In-the-money supply · most strikes not on record
31.5M
Potential new shares
Dec 2031
Nearest expiry
What this supply is, and what converts it
  • Price-triggered30.5M · 19.7% of shares
    Options and warrants — they convert when the share price clears their exercise price.
    At least 26.6M of it states no exercise price — that much cannot be called in or out of the money.
  • Condition-triggered926k · 0.6% of shares
    Performance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.

Exercise price on record: 3.9M priced (of which 854k in the money), 27.5M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.

Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.

What a price move would switch on
15.7M31.5M$4.51 now0.25× today ($1.13) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($2.25) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($3.38) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($4.51) — 854k of the priced supply in the money, 0.6% of shares on issue1.25× today ($5.64) — 1.1M of the priced supply in the money, 0.7% of shares on issue1.5× today ($6.76) — 1.1M of the priced supply in the money, 0.7% of shares on issue2× today ($9.02) — 2.6M of the priced supply in the money, 1.7% of shares on issue3× today ($13.53) — 3.4M of the priced supply in the money, 2.2% of shares on issue5× today ($22.55) — 3.9M of the priced supply in the money, 2.5% of shares on issue10× today ($45.10) — 3.9M of the priced supply in the money, 2.5% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $4.51 today, 854k securities are in the money (0.6% of shares on issue) — a floor, because an exercise price is on record for only 12.5% of this supply. No more priced supply until 1.25× today’s price, which takes it to 1.1M (0.7% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 27.5M (87.5% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
AVHAAKOptionsPrice-triggered$12.1823 Dec 203113kFiling
AVHAALOptionsPrice-triggered$12.153 Jan 20327kFiling
AVHAAMOptionsPrice-triggered$8.601 Apr 20325kFiling
AVHAANOptionsPrice-triggered$4.971 July 2032135kFiling
AVHAAOOptionsPrice-triggered$5.6420 July 20324kFiling
AVHAAPOptionsPrice-triggered$5.165 Oct 20322kFiling
AVHAAROptionsPrice-triggered$6.9513 Dec 203216kFiling
AVHAASOptionsPrice-triggered$6.475 Jan 20335kFiling
AVHAATOptionsPrice-triggered$9.0624 Feb 20333kFiling
AVHAAUOptionsPrice-triggered$15.2510 May 203375kFiling
AVHAAVOptionsPrice-triggered$14.177 June 2033206kFiling
AVHAAWOptionsPrice-triggered$17.0016 June 2033150kFiling
AVHAAXOptionsPrice-triggered$17.011 July 203330kFiling
AVHABAOptionsPrice-triggered$13.4315 Nov 203353kFiling
AVHABIOptionsPrice-triggered$12.644 Jan 2034126kFiling
AVHABBOptionsPrice-triggered$12.644 Jan 2034503kFiling
AVHABCOptionsPrice-triggered$13.499 Jan 203490kFiling
AVHABDOptionsPrice-triggered$15.0624 Jan 203433kFiling
AVHABGOptionsPrice-triggered$8.8130 May 20347kFiling
AVHABHOptionsPrice-triggered$9.516 June 203420kFiling
AVHABJOptionsPrice-triggered$7.722 July 2034151kFiling
AVHABKOptionsPrice-triggered$9.801 Aug 203430kFiling
AVHABLOptionsPrice-triggered$8.077 Aug 2034115kFiling
AVHABNOptionsPrice-triggered$8.847 Sept 203430kFiling
AVHABOOptionsPrice-triggered$10.2618 Sept 203414kFiling
AVHABPOptionsPrice-triggered$8.7322 Jan 20351.1MFiling
AVHABQOptionsPrice-triggered$9.101 Feb 203510kFiling
AVHABROptionsPrice-triggered$8.688 Feb 203533kFiling
AVHABSOptionsPrice-triggered$8.9515 Apr 203548kFiling
AVHABTOptionsPrice-triggered$5.5414 June 203518kFiling
AVHABUOptionsPrice-triggered$5.178 July 203540kFiling
AVHABOptionsPrice-triggered$5.366 Aug 203519kFiling
AVHABWOptionsPrice-triggered$4.8111 Aug 20355kFiling
AVHABVOptionsPrice-triggered$5.5519 Aug 20354kFiling
AVHACOptionsPrice-triggered$3.475 Jan 203629kFiling
AVHAAOptionsPrice-triggered$3.7721 Jan 203697kFiling
AVHAGOptionsPrice-triggered$4.3118 Feb 2036727kFiling
AVHADOptionsPrice-triggered$8.2011 Aug 203625kFiling
AVHAABOptionsPrice-triggered, no exercise price stated——4kFiling
AVHAAHOptionsPrice-triggered, no exercise price stated——4kFiling
AVHAAEOptionsPrice-triggered, no exercise price stated——10kFiling
AVHAAJOptionsPrice-triggered, no exercise price stated——13kFiling
AVHAAGOptionsPrice-triggered, no exercise price stated——22kFiling
AVHAAIOptionsPrice-triggered, no exercise price stated——27kFiling
AVHAACOptionsPrice-triggered, no exercise price stated——68kFiling
AVHAAA—Condition-triggered——926kFiling Meeting
AVHAAZWarrantsPrice-triggered, no exercise price stated——1.1MFiling
AVHAEOptionsPrice-triggered, no exercise price stated——25.4MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.

A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.

3 classes ceased in the last 12 months and are not counted above
The company’s own Appendix 2A restates each of these at zero. They are excluded from the overhang, the in-the-money supply and every figure on this page. Each count is the filing’s own count of securities in the class, not a share count — a 2A never states what one security converts into.
  • AVHAAQPrice-triggered170k securities → 06 Aug 2026 Appendix 2A
  • AVHAFPrice-triggered30k securities → 06 Aug 2026 Appendix 2A
  • AVHABEPrice-triggered20k securities → 03 July 2026 Appendix 2A
Free account
48 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Unlock AVH freeSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
6 Aug 2026Dr. Michael TarnoffOther9k—48k—3Y notice
3 June 2026Cary G. VanceOther3k———3Y notice
3 June 2026Dr. Michael TarnoffOther—19k48k—3Y notice
3 June 2026Jan Stern ReedOther—16k22k—3Y notice
3 June 2026Jeremy Curnock CookOther22k16k——3Y notice
3 June 2026Professor Suzanne CroweOther22k16k——3Y notice
3 June 2026Robert McNamaraOther3k16k22k—3Y notice
Free account
27 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock AVH freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

21 Oct 2026AVITA to announce Q3 financial results November 6 AEDT
7 Oct 2026Statement of CDIs on issue - AVH
6 Oct 2026Change of Director's Interest Notice - MT
6 Oct 2026Notification regarding unquoted securities - AVH
6 Oct 2026Notification of cessation of securities - AVH
15 Sept 2026Notification of cessation of securities - AVH
11 Sept 2026Statement of CDIs on issue - AVH
10 Sept 2026Notification regarding unquoted securities - AVH
10 Sept 2026Notification regarding unquoted securities - AVH
9 Sept 2026Notification regarding unquoted securities - AVH
7 Sept 2026Notification of cessation of securities - AVH
3 Sept 2026AVITA to participate in US bank investor conferences
19 Aug 2026AVITA Investor Webinar Slides on PermeaDerm
19 Aug 2026$PAVITA announces positive PermeaDerm study results
12 Aug 2026Notification regarding unquoted securities - AVH
10 Aug 2026AVITA Medical Investor Presentation August 2026
10 Aug 2026AVITA Medical to Host Investor Webinar Briefing
10 Aug 2026AVITA to participate at Canaccord Genuity Growth Conference
7 Aug 2026Statement of CDIs on issue - AVH
7 Aug 2026$PAVITA 10-Q Quarterly Report for Q2 2026

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.